· 2022–2024 · DOL EFAST2
Search
Browse
Resources
Pricing
X4 PHARMACEUTICALS INC. — X4 PHARMACEUTICALS INC. 401(K) PLAN, Form 5500 (2024) | Form 5500 Search
Back to filter
Original filing (PDF)
20250801072142NAL0003645507001
X4 PHARMACEUTICALS INC.
Form 5500-SF
FILING_RECEIVED
X4 PHARMACEUTICALS INC. 401(K) PLAN
401(k) retirement plan
Signals · 1
No auditor on file
Active participants
135
Accounts w/ balance
146
Plan assets (EOY)
$12.5M
Net assets (EOY)
$12.5M
Plan health score (directional)
77
/ 100
Grade B
Above-average plan
Directional indicator computed from public Form 5500 data — compliance, concentration, cost, vendor stack and participation. Not a fiduciary tool.
Compliance & disclosures
60
Concentration risk
75
Total plan cost
75
Vendor stack
100
Participation health
Decision-maker contacts
CFO / Head of HR / Benefits Manager — verified email + LinkedIn for
X4 PHARMACEUTICALS INC.
.
Find decision makers
Plan sponsor
Name
X4 PHARMACEUTICALS INC.
EIN
27-3181608
Address
61 N BEACON ST 4TH FLOOR · BOSTON, MA · 02134
Phone
(781) 258-0080
Industry
Manufacturing
see all
Plan administrator
Same as plan sponsor.
Plan characteristics
Plan number
001
Plan year
2024
Plan year begin
2024-01-01
Tax period
2024-12-31
Filed
2025-08-01
Pension benefit codes
2E · Profit-sharing
2F · ERISA section 404(c)
2G · Total participant-directed accounts
2J · 401(k) feature
2K · 401(m) arrangement
2T · Default investment account (QDIA)
3D · Pre-approved plan (master / prototype / VS)
Audit & trust (Schedule H)
Service providers (Schedule C)
Small plans don't disclose service providers
Related plans
Similar-size Manufacturing plans
APTEVO THERAPEUTIC, INC.
APTEVO THERAPEUTICS DEFINED COMPENSATION PLAN
$12.5M · 38 participants
FOGHORN THERAPEUTICS INC
FOGHORN THERAPEUTICS 401(K) PLAN
$12.6M · 113 participants
NEXUS PHARMACEUTICALS, LLC
NEXUS PHARMACEUTICALS, LLC 401(K) AND PROFIT SHARING PLAN
$12.3M · 94 participants
SKILLED CARE PHARMACY, INC.
SKILLED CARE PHARMACY, INC. 401(K) PLAN
$12.3M · 76 participants
TEIKOKU PHARMA USA, INC.
TEIKOKU PHARMA USA, INC 401(K) PLAN
100
Knocking points off
No independent qualified public accountant (IQPA) named.
Helping the score
Concentration not scored — Schedule of Assets PDF not yet parsed for this plan.
No Schedule C compensation disclosed — likely a small plan or unbundled.
Auditor
—
Trustee / custodian
—
Trustee phone
—
Small plan (5500-SF) — Schedule H data not available.
$12.7M · 30 participants
ZYMEWORKS BIOPHARMACEUTICALS INC.
ZYMEWORKS BIOPHARMACEUTICALS 401(K) PLAN
$12.2M · 76 participants
Large plans in Massachusetts
FIDELITY MANAGEMENT TRUST COMPANY
FIDELITY GROWTH COMPANY COMMINGLED POOL
$91.5B
STATE STREET GLOBAL ADVISORS TRUST COMPANY
STATE STREET S&P 500(R) INDEX NON-LENDING SERIES FUND CLASS A
$91.0B
FIDELITY MANAGEMENT TRUST COMPANY
FIDELITY CONTRAFUND COMMINGLED POOL
$59.7B
STATE STREET GLOBAL ADVISORS TRUST COMPANY
STATE STREET S&P 500(R) INDEX SECURITIES LENDING SERIES FUND CLASS I
$53.6B
GEODE CAPITAL MANAGEMENT TRUST COMPANY, LLC
SPARTAN GROUP TRUST FOR EMPLOYEE BENEFIT PLANS SPARTAN 500 INDEX POOL
$47.6B
STATE STREET GLOBAL ADVISORS TRUST COMPANY
STATE STREET S&P 500(R) INDEX SECURITIES LENDING SERIES FUND CLASS II
$46.7B
